安非他酮 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "安非他酮" in Chinese language version.

refsWebsite

Global rank Chinese rank

56doi.org

2^nd place

23^rd place

55web.archive.org

1^st place

44nih.gov

4^th place

5^th place

43worldcat.org

5^th place

12^th place

14fda.gov

447^th place

581^st place

9elsevier.com

610^th place

388^th place

7lww.com

2,769^th place

1,362^nd place

6wiley.com

222^nd place

216^th place

3books.google.com

3^rd place

8^th place

3springer.com

274^th place

320^th place

3europa.eu

68^th place

209^th place

2tga.gov.au

3,984^th place

1,603^rd place

2psychiatrist.com

low place

2jamanetwork.com

2,650^th place

1,976^th place

1medicines.org.uk

3,823^rd place

3,456^th place

1medicinescomplete.com

low place

9,960^th place

1fda.gov.tw

low place

1,125^th place

1google.com

163^rd place

188^th place

1biomedcentral.com

2,747^th place

1,988^th place

1liebertpub.com

low place

6,142^nd place

1annals.org

low place

6,426^th place

1tandfonline.com

507^th place

610^th place

1acs.org

1,248^th place

434^th place

1aerzteblatt.de

3,043^rd place

9,194^th place

1ualberta.ca

3,600^th place

2,954^th place

1aspetjournals.org

6,663^rd place

8,533^rd place

1psychiatryonline.org

4,032^nd place

4,931^st place

1emedexpert.com

low place

1drugabuse.gov

6,166^th place

3,264^th place

1cnn.com

28^th place

71^st place

1peoplespharmacy.com

low place

1nbcnews.com

137^th place

538^th place

1medscape.com

719^th place

889^th place

1wikipedia.org

low place

1nytimes.com

7^th place

31^st place

1pharmaceutical-journal.com

low place

acs.org

pubs.acs.org

Shalabi, Abdelrahman R.; Walther, Donna; Baumann, Michael H.; Glennon, Richard A. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. ACS Chemical Neuroscience. 2017-06-21, 8 (6). ISSN 1948-7193. PMC 7261150 . PMID 28220701. doi:10.1021/acschemneuro.7b00055 （英语）.

aerzteblatt.de

Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. Antidepressant Withdrawal and Rebound Phenomena. Deutsches Ärzteblatt international. 2019-05-17. ISSN 1866-0452. PMC 6637660 . PMID 31288917. doi:10.3238/arztebl.2019.0355.

annals.org

Li, Zhaoping; Maglione, Margaret; Tu, Wenli; Mojica, Walter; Arterburn, David; Shugarman, Lisa R.; Hilton, Lara; Suttorp, Marika; Solomon, Vanessa; Shekelle, Paul G.; Morton, Sally C. Meta-Analysis: Pharmacologic Treatment of Obesity. Annals of Internal Medicine. 2005-04-05, 142 (7). ISSN 0003-4819. doi:10.7326/0003-4819-142-7-200504050-00012 （英语）.

aspetjournals.org

jpet.aspetjournals.org

Schmid, Yasmin; Rickli, Anna; Schaffner, Antonia; Duthaler, Urs; Grouzmann, Eric; Hysek, Cédric M.; Liechti, Matthias E. Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 2015-04, 353 (1). ISSN 0022-3565. doi:10.1124/jpet.114.222356 （英语）.

biomedcentral.com

bmcpublichealth.biomedcentral.com

Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12, 6 (1) [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2025-03-02）（英语）.

books.google.com

Dr. Ian Morton, I.K. Morton, Judith M. Hall. Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. 31 October 1999: 57– [2015-09-02]. ISBN 978-0-7514-0499-9. （原始内容存档于2016-04-27）.
Dictionary of Organic Compounds. CRC Press. : 104– [2015-09-02]. ISBN 978-0-412-54090-5. （原始内容存档于2016-04-30）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000: 38– [2015-09-02]. ISBN 978-3-88763-075-1. （原始内容存档于2016-04-30）.

cnn.com

Seasonal affective disorder drug Wellbutrin XL wins approval [季节性情感障碍药物Wellbutrin XL获批准]. CNN. 14 June 2006 [19 August 2007]. （原始内容存档于30 June 2007）（英语）.

doi.org

Zhu, A. Z. X.; Zhou, Q.; Cox, L. S.; Ahluwalia, J. S.; Benowitz, N. L.; Tyndale, R. F. Gene Variants in CYP2C19 Are Associated with Altered In Vivo Bupropion Pharmacokinetics but Not Bupropion-Assisted Smoking Cessation Outcomes. Drug Metabolism and Disposition. 3 September 2014, 42 (11): 1971–1977. PMID 25187485. doi:10.1124/dmd.114.060285.
Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs. 2009,. 23 Suppl 1: 21–31. PMID 19621975. doi:10.2165/00023210-200923000-00004.
Childress, A. C.; Sallee, F. R. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder. Drugs of Today (Barcelona, Spain: 1998). 2012, 48 (3): 207–217. ISSN 1699-3993. PMID 22462040. doi:10.1358/dot.2012.48.3.1750904.
Cipriani, Andrea; Furukawa, Toshiaki A; Salanti, Georgia; Geddes, John R; Higgins, Julian PT; Churchill, Rachel; Watanabe, Norio; Nakagawa, Atsuo; Omori, Ichiro M; McGuire, Hugh; Tansella, Michele. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009-02, 373 (9665) [2024-09-28]. doi:10.1016/S0140-6736(09)60046-5. （原始内容存档于2025-03-31）（英语）.
Monden, Rei; Roest, Annelieke M.; van Ravenzwaaij, Don; Wagenmakers, Eric-Jan; Morey, Richard; Wardenaar, Klaas J.; de Jonge, Peter. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews. Journal of Affective Disorders. 2018-08, 235 [2024-09-28]. doi:10.1016/j.jad.2018.04.040. （原始内容存档于2024-09-19）（英语）.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018-04, 391 (10128) [2024-09-28]. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7. （原始内容存档于2025-02-17）（英语）.
Hengartner, Michael P.; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PLoS ONE. 2020-02-26, 15 (2). ISSN 1932-6203. PMC 7043778 . PMID 32101579. doi:10.1371/journal.pone.0229381.
Stone, Marc B; Yaseen, Zimri S; Miller, Brian J; Richardville, Kyle; Kalaria, Shamir N; Kirsch, Irving. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. The BMJ. 2022-08-02, 378 [2024-09-28]. ISSN 0959-8138. PMC 9344377 . PMID 35918097. doi:10.1136/bmj-2021-067606. （原始内容存档于2024-06-11）.
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology. 2016-04, 6 (2). ISSN 2045-1253. PMC 4837968 . PMID 27141292. doi:10.1177/2045125316629071.
Gartlehner, Gerald; Nussbaumer‐Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G; Winkler, Dietmar. Second‐generation antidepressants for preventing seasonal affective disorder in adults. The Cochrane Database of Systematic Reviews. 2019-03-18, 2019 (3) [2024-09-28]. ISSN 1469-493X. PMC 6422318 . PMID 30883669. doi:10.1002/14651858.CD011268.pub3. （原始内容存档于2024-10-06）.
Li, Dian-Jeng; Tseng, Ping-Tao; Chen, Yen-Wen; Wu, Ching-Kuan; Lin, Pao-Yen. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines. Medicine. 2016-03, 95 (13). ISSN 0025-7974. PMC 4998539 . PMID 27043678. doi:10.1097/MD.0000000000003165 （英语）.
Dhillon, Sohita; Yang, Lily P H; Curran, Monique P. Bupropion: A Review of its Use in the Management of Major Depressive Disorder. Drugs. 2008, 68 (5). ISSN 0012-6667. doi:10.2165/00003495-200868050-00011 （英语）.
Papakostas, George I.; Stahl, Stephen M.; Krishen, Alok; Seifert, Cheryl A.; Tucker, Vivian L.; Goodale, Elizabeth P.; Fava, Maurizio. Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression): A Pooled Analysis of 10 Studies. The Journal of Clinical Psychiatry. 2008-08-15, 69 (8). ISSN 0160-6689. doi:10.4088/JCP.v69n0812.
Naguy, Ahmed; Badr, Bassem H. M. Bupropion-myth-busting!. CNS spectrums. 2022-10, 27 (5). ISSN 1092-8529. PMID 33843549. doi:10.1017/S1092852921000365.
Hajizadeh, Anisa; Howes, Seth; Theodoulou, Annika; Klemperer, Elias; Hartmann-Boyce, Jamie; Livingstone-Banks, Jonathan; Lindson, Nicola. Cochrane Tobacco Addiction Group , 编. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews. 2023-05-24, 2023 (5). PMC 10207863 . PMID 37230961. doi:10.1002/14651858.CD000031.pub6 （英语）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12-11, 6 [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2023-10-11）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12, 6 (1) [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2025-03-02）（英语）.
Rosen, Laura J.; Galili, Tal; Kott, Jeffrey; Goodman, Mark; Freedman, Laurence S. Diminishing benefit of smoking cessation medications during the first year: a meta‐analysis of randomized controlled trials. Addiction. 2018-05, 113 (5) [2024-09-30]. ISSN 0965-2140. doi:10.1111/add.14134. （原始内容存档于2025-04-09）（英语）.
Livingstone-Banks, Jonathan; Norris, Emma; Hartmann-Boyce, Jamie; West, Robert; Jarvis, Martin; Chubb, Emma; Hajek, Peter. Cochrane Tobacco Addiction Group , 编. Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2019-10-28. doi:10.1002/14651858.CD003999.pub6 （英语）.
Patnode, Carrie D.; Henderson, Jillian T.; Coppola, Erin L.; Melnikow, Joy; Durbin, Shauna; Thomas, Rachel G. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021-01-19, 325 (3). ISSN 0098-7484. doi:10.1001/jama.2020.23541 （英语）.
Selph, Shelley; Patnode, Carrie; Bailey, Steffani R.; Pappas, Miranda; Stoner, Ryan; Chou, Roger. Primary Care–Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020-04-28, 323 (16) [2024-09-30]. ISSN 0098-7484. doi:10.1001/jama.2020.3332. （原始内容存档于2025-03-17）（英语）.
Claire, Ravinder; Chamberlain, Catherine; Davey, Mary-Ann; Cooper, Sue E; Berlin, Ivan; Leonardi-Bee, Jo; Coleman, Tim. Cochrane Tobacco Addiction Group , 编. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2020-03-04, 2020 (3). doi:10.1002/14651858.CD010078.pub3 （英语）.
Wolraich, Mark L.; Hagan, Joseph F.; Allan, Carla; Chan, Eugenia; Davison, Dale; Earls, Marian; Evans, Steven W.; Flinn, Susan K.; Froehlich, Tanya; Frost, Jennifer; Holbrook, Joseph R. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019-10, 144 (4). ISSN 0031-4005. PMC 7067282 . PMID 31570648. doi:10.1542/peds.2019-2528.
Verbeeck, Wim; Bekkering, Geertruida E; Van den Noortgate, Wim; Kramers, Cornelis. Cochrane Developmental, Psychosocial and Learning Problems Group , 编. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews. 2017-10-02, 2017 (10). PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2 （英语）.
Elliott, Jesse; Johnston, Amy; Husereau, Don; Kelly, Shannon E.; Eagles, Caroline; Charach, Alice; Hsieh, Shu-Ching; Bai, Zemin; Hossain, Alomgir; Skidmore, Becky; Tsakonas, Eva. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS ONE. 2020-10-21, 15 (10). ISSN 1932-6203. PMC 7577505 . PMID 33085721. doi:10.1371/journal.pone.0240584.
Cortese, Samuele; Adamo, Nicoletta; Del Giovane, Cinzia; Mohr-Jensen, Christina; Hayes, Adrian J; Carucci, Sara; Atkinson, Lauren Z; Tessari, Luca; Banaschewski, Tobias; Coghill, David; Hollis, Chris. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-09, 5 (9). ISSN 2215-0366. PMC 6109107 . PMID 30097390. doi:10.1016/S2215-0366(18)30269-4.
Ng, Qin Xiang. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 2017-03, 27 (2). ISSN 1044-5463. doi:10.1089/cap.2016.0124 （英语）.
Wilens, Timothy E; Morrison, Nicholas R; Prince, Jefferson. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert review of neurotherapeutics. 2011-10, 11 (10) [2024-09-29]. ISSN 1473-7175. PMC 3229037 . PMID 21955201. doi:10.1586/ern.11.137. （原始内容存档于2023-09-25）.
Li, Zhaoping; Maglione, Margaret; Tu, Wenli; Mojica, Walter; Arterburn, David; Shugarman, Lisa R.; Hilton, Lara; Suttorp, Marika; Solomon, Vanessa; Shekelle, Paul G.; Morton, Sally C. Meta-Analysis: Pharmacologic Treatment of Obesity. Annals of Internal Medicine. 2005-04-05, 142 (7). ISSN 0003-4819. doi:10.7326/0003-4819-142-7-200504050-00012 （英语）.
Costa, Rafaela; Oliveira, Nuno G.; Dinis-Oliveira, Ricardo Jorge. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metabolism Reviews. 2019-07-03, 51 (3). ISSN 0360-2532. doi:10.1080/03602532.2019.1620763 （英语）.
Shalabi, Abdelrahman R.; Walther, Donna; Baumann, Michael H.; Glennon, Richard A. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. ACS Chemical Neuroscience. 2017-06-21, 8 (6). ISSN 1948-7193. PMC 7261150 . PMID 28220701. doi:10.1021/acschemneuro.7b00055 （英语）.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10). ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10) [2025-03-22]. ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2. （原始内容存档于2025-02-03）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R.A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1) [2025-03-22]. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077. （原始内容存档于2025-02-06）（英语）.
Rau, Kristi S.; Birdsall, Elisabeth; Hanson, Jarom E.; Johnson-Davis, Kamisha L.; Carroll, F. Ivy; Wilkins, Diana G.; Gibb, James W.; Hanson, Glen R.; Fleckenstein, Annette E. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 2005-11, 49 (6). doi:10.1016/j.neuropharm.2005.05.004 （英语）.
Jefferson, James W.; Pradko, James F.; Muir, Keith T. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clinical Therapeutics. 2005-11, 27 (11). doi:10.1016/j.clinthera.2005.11.011 （英语）.
Hesse, Leah M; He, Ping; Krishnaswamy, Soundararajan; Hao, Qin; Hogan, Kirk; Moltke, Lisa Lvon; Greenblatt, David J; Court, Michael H. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes:. Pharmacogenetics. 2004-04, 14 (4). ISSN 0960-314X. doi:10.1097/00008571-200404000-00002 （英语）.
Alberti, Siegfried; Chiesa, Alberto; Andrisano, Costanza; Serretti, Alessandro. Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression: A Meta-Analysis. Journal of Clinical Psychopharmacology. 2015-06, 35 (3). ISSN 0271-0749. doi:10.1097/JCP.0000000000000329 （英语）.
Telang, Shilpa; Walton, Celeste; Olten, Baris; Bloch, Michael H. Meta-analysis: Second generation antidepressants and headache. Journal of Affective Disorders. 2018-08, 236. doi:10.1016/j.jad.2018.04.047 （英语）.
Pisani, Francesco; Oteri, Giancarla; Costa, Cinzia; Di Raimondo, Giorgio; Di Perri, Raoul. Effects of Psychotropic Drugs on Seizure Threshold:. Drug Safety. 2002, 25 (2). ISSN 0114-5916. doi:10.2165/00002018-200225020-00004 （英语）.
Etminan, Mahyar; Sodhi, Mohit; Procyshyn, Ric M.; Guo, Michael; Carleton, Bruce C. Risk of hair loss with different antidepressants: a comparative retrospective cohort study. International Clinical Psychopharmacology. 2018-01, 33 (1). ISSN 0268-1315. doi:10.1097/YIC.0000000000000191 （英语）.
Kumar, Sanjeev; Kodela, Sreekant; Detweiler, Jonna G.; Kim, Kye Y.; Detweiler, Mark B. Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. General Hospital Psychiatry. 2011-11, 33 (6). doi:10.1016/j.genhosppsych.2011.07.001 （英语）.
Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. Antidepressant Withdrawal and Rebound Phenomena. Deutsches Ärzteblatt international. 2019-05-17. ISSN 1866-0452. PMC 6637660 . PMID 31288917. doi:10.3238/arztebl.2019.0355.
Ketter, Terence A.; Jenkins, Janice B.; Schroeder, David H.; Pazzaglia, Peggy J.; Marangell, Lauren B.; George, Mark S.; Callahan, Ann M.; Hinton, Melvin L.; Chao, John; Post, Robert M. Carbamazepine but not Valproate Induces Bupropion Metabolism:. Journal of Clinical Psychopharmacology. 1995-10, 15 (5). ISSN 0271-0749. doi:10.1097/00004714-199510000-00004 （英语）.
Todor, Ioana; Popa, Adina; Neag, Maria; Muntean, Dana; Bocsan, Corina; Buzoianu, Anca; Vlase, Laurian; Gheldiu, Ana-Maria; Briciu, Corina. Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. Journal of Pharmacy & Pharmaceutical Sciences. 2016-06-15, 19 (2). ISSN 1482-1826. doi:10.18433/J3H03R.
Schmid, Yasmin; Rickli, Anna; Schaffner, Antonia; Duthaler, Urs; Grouzmann, Eric; Hysek, Cédric M.; Liechti, Matthias E. Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 2015-04, 353 (1). ISSN 0022-3565. doi:10.1124/jpet.114.222356 （英语）.
Protti, Michele; Mandrioli, Roberto; Marasca, Camilla; Cavalli, Andrea; Serretti, Alessandro; Mercolini, Laura. New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews. 2020-09, 40 (5). ISSN 0198-6325. doi:10.1002/med.21671 （英语）.
Spina, Edoardo; Santoro, Vincenza; D'Arrigo, Concetta. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clinical Therapeutics. 2008-07, 30 (7). doi:10.1016/S0149-2918(08)80047-1 （英语）.
Feinberg, S. Shalom. Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication. The Journal of Clinical Psychiatry. 2004-11-15, 65 (11) [2024-10-02]. ISSN 0160-6689. doi:10.4088/JCP.v65n1113. （原始内容存档于2025-01-12）.
White, Nicole C.; Litovitz, Toby; Clancy, Cathleen. Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology. 2008-12, 4 (4). ISSN 1556-9039. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207 （英语）.
Nelson, J. Craig; Spyker, Daniel A. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. American Journal of Psychiatry. 2017-05-01, 174 (5). ISSN 0002-953X. doi:10.1176/appi.ajp.2016.16050523 （英语）.
Fava M, Rush AJ, Thase ME, Clayton A, Stahl SM, Pradko JF, Johnston JA. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL [15年盐酸安非他酮临床经验：从安非他酮到安非他酮SR再到安非他酮XL]. Primary Care Companion to the Journal of Clinical Psychiatry. 2005, 7 (3): 106–113. PMC 1163271 . PMID 16027765. doi:10.4088/pcc.v07n0305 （英语）.

drugabuse.gov

Whitten L. Bupropion helps people with schizophrenia quit smoking [安非他酮帮助精神分裂症患者戒烟]. National Institute on Drug Abuse Research Findings. April 2006, 20 (5) [27 May 2013]. （原始内容存档于5 August 2007）（英语）.

elsevier.com

linkinghub.elsevier.com

Cipriani, Andrea; Furukawa, Toshiaki A; Salanti, Georgia; Geddes, John R; Higgins, Julian PT; Churchill, Rachel; Watanabe, Norio; Nakagawa, Atsuo; Omori, Ichiro M; McGuire, Hugh; Tansella, Michele. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009-02, 373 (9665) [2024-09-28]. doi:10.1016/S0140-6736(09)60046-5. （原始内容存档于2025-03-31）（英语）.
Monden, Rei; Roest, Annelieke M.; van Ravenzwaaij, Don; Wagenmakers, Eric-Jan; Morey, Richard; Wardenaar, Klaas J.; de Jonge, Peter. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews. Journal of Affective Disorders. 2018-08, 235 [2024-09-28]. doi:10.1016/j.jad.2018.04.040. （原始内容存档于2024-09-19）（英语）.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018-04, 391 (10128) [2024-09-28]. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7. （原始内容存档于2025-02-17）（英语）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R.A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1) [2025-03-22]. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077. （原始内容存档于2025-02-06）（英语）.
Rau, Kristi S.; Birdsall, Elisabeth; Hanson, Jarom E.; Johnson-Davis, Kamisha L.; Carroll, F. Ivy; Wilkins, Diana G.; Gibb, James W.; Hanson, Glen R.; Fleckenstein, Annette E. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 2005-11, 49 (6). doi:10.1016/j.neuropharm.2005.05.004 （英语）.
Jefferson, James W.; Pradko, James F.; Muir, Keith T. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clinical Therapeutics. 2005-11, 27 (11). doi:10.1016/j.clinthera.2005.11.011 （英语）.
Telang, Shilpa; Walton, Celeste; Olten, Baris; Bloch, Michael H. Meta-analysis: Second generation antidepressants and headache. Journal of Affective Disorders. 2018-08, 236. doi:10.1016/j.jad.2018.04.047 （英语）.
Kumar, Sanjeev; Kodela, Sreekant; Detweiler, Jonna G.; Kim, Kye Y.; Detweiler, Mark B. Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. General Hospital Psychiatry. 2011-11, 33 (6). doi:10.1016/j.genhosppsych.2011.07.001 （英语）.
Spina, Edoardo; Santoro, Vincenza; D'Arrigo, Concetta. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clinical Therapeutics. 2008-07, 30 (7). doi:10.1016/S0149-2918(08)80047-1 （英语）.

emedexpert.com

Bupropion (Wellbutrin) [安非他酮（Wellbutrin）]. eMedExpert.com. 31 March 2008 [20 August 2013]. （原始内容存档于6 August 2013）（英语）.

europa.eu

ema.europa.eu

Committee for Medicinal Products for Human Use (CHMP). EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs [EMA建议由于Micro Therapeutic Research Labs的不可靠研究而暂停药品]. European Medicines Agency. 24 March 2017 [26 November 2020]. （原始内容存档于26 October 2020）（英语）.
Committee for Medicinal Products for Human Use (CHMP). Products for which the marketing authorisations are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP [CHMP建议暂停上市许可的产品和不符合授权标准的上市许可申请] (PDF). European Medicines Agency. 23 March 2017 [26 November 2020]. （原始内容存档 (PDF)于19 January 2021）（英语）.
EMA advises companies on steps to take avoid nitrosamines in human medicines [EMA建议公司采取措施避免人用药品中的亚硝胺]. European Medicines Agency (EMA). 26 September 2019 [24 October 2023]. （原始内容存档于11 November 2023）（英语）.

fda.gov

accessdata.fda.gov

Highlight os Prescribing Information: CONTRAVE (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use (PDF). [2024-10-02]. （原始内容存档 (PDF)于2020-10-19）（英语）.
Wellbutrin approval package [Wellbutrin批准文件] (PDF). U.S. 美国食品药品监督管理局 (FDA). 30 December 1985 [5 May 2020]. （原始内容存档 (PDF)于27 November 2020）（英语）.
Wellbutrin entry in the Orange Book [Wellbutrin在橙皮书中的条目]. U.S. Food and Drug Administration Center for Drug Evaluation and Research. [18 August 2007]. （原始内容存档于25 February 2011）（英语）.
Drug Approval Package: Wellbutrin XL (Bupropion HCI) NDA #021515 [药物批准包：Wellbutrin XL（盐酸安非他酮）NDA #021515]. U.S. 美国食品药品监督管理局 (FDA). 22 April 2005 [4 December 2019]. （原始内容存档于5 December 2019）（英语）.
Drug Approval Package: Zyban NDA# 020711 [药物批准包：Zyban NDA# 020711]. U.S. 美国食品药品监督管理局 (FDA). 8 August 2003 [4 December 2019]. （原始内容存档于5 December 2019）（英语）.
FDA approval letter [FDA批准信] (PDF). U.S. 美国食品药品监督管理局 (FDA). 6 December 2006 [21 October 2020]. （原始内容存档 (PDF)于1 November 2020）（英语）.
Drug Approval Package: Aplenzin (Bupropion Hydrobromide) NDA 22108 [药物批准包：Aplenzin（氢溴酸安非他酮）NDA 22108]. U.S. 美国食品药品监督管理局 (FDA). 24 December 1999 [5 May 2020]. （原始内容存档于15 August 2020）（英语）.
CENTER FOR DRUG EVALUATION AND RESEARCH. Application number 22-108 Cross Dicipline Team Leader Review (PDF). accessdata.fda.gov. [2025-03-09]. （原始内容存档 (PDF)于2025-02-08）.

fda.gov

"Antidepressants and suicidality in adults: statistical evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)". （原始内容存档于2007-07-27）（英语）.
Review of therapeutic equivalence: generic bupropion XL 300 mg and Wellbutrin XL 300 mg [治疗等效性评审：仿制安非他酮XL 300毫克和Wellbutrin XL 300毫克]. 美国食品药品监督管理局. [19 April 2008]. （原始内容存档于6 June 2011）（英语）.
Budeprion XL 300 mg not therapeutically equivalent to Wellbutrin XL 300 mg [Budeprion XL 300毫克与Wellbutrin XL 300毫克不具有治疗等效性]. U.S. 美国食品药品监督管理局 (FDA). 3 October 2012 [23 March 2013]. （原始内容存档于13 December 2019）（英语）. 本文含有此來源中屬於公有领域的内容。
Public Health Advisory: FDA requires new boxed warnings for the smoking cessation drugs Chantix and Zyban [公共卫生警告：FDA要求戒烟药物Chantix和Zyban加注新的黑框警告]. U.S. 美国食品药品监督管理局 (FDA). 1 July 2009 [3 July 2009]. （原始内容存档于19 October 2010）（英语）.
The smoking cessation aids varenicline (marketed as Chantix) and bupropion (marketed as Zyban and generics) suicidal ideation and behavior [戒烟辅助药物伐尼克兰（商品名Chantix）和安非他酮（商品名Zyban及仿制药）的自杀意念和行为] (PDF). Drug Safety Newsletter. 2009, 2 (1): 1–4 [16 December 2019]. （原始内容 (PDF)存档于11 February 2017）（英语）.
Safety Alerts for Human Medical Products – Chantix (varenicline) and Zyban (bupropion) [人用医疗产品安全警报 - Chantix (伐尼克兰) 和 Zyban (安非他酮) - 药物安全通讯 - 精神健康副作用修订]. Drug Safety Communication – Mental Health Side Effects Revised. U.S. 美国食品药品监督管理局 (FDA). 16 December 2016 [20 December 2016]. （原始内容存档于20 December 2016）（英语）.

fda.gov.tw

info.fda.gov.tw

衛署藥製字第054977號. info.fda.gov.tw. [2022-02-20]. （原始内容存档于2022-02-20）.

google.com

美國專利第3,819,706号

jamanetwork.com

Patnode, Carrie D.; Henderson, Jillian T.; Coppola, Erin L.; Melnikow, Joy; Durbin, Shauna; Thomas, Rachel G. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021-01-19, 325 (3). ISSN 0098-7484. doi:10.1001/jama.2020.23541 （英语）.
Selph, Shelley; Patnode, Carrie; Bailey, Steffani R.; Pappas, Miranda; Stoner, Ryan; Chou, Roger. Primary Care–Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020-04-28, 323 (16) [2024-09-30]. ISSN 0098-7484. doi:10.1001/jama.2020.3332. （原始内容存档于2025-03-17）（英语）.

liebertpub.com

Ng, Qin Xiang. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 2017-03, 27 (2). ISSN 1044-5463. doi:10.1089/cap.2016.0124 （英语）.

lww.com

journals.lww.com

Li, Dian-Jeng; Tseng, Ping-Tao; Chen, Yen-Wen; Wu, Ching-Kuan; Lin, Pao-Yen. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines. Medicine. 2016-03, 95 (13). ISSN 0025-7974. PMC 4998539 . PMID 27043678. doi:10.1097/MD.0000000000003165 （英语）.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Hesse, Leah M; He, Ping; Krishnaswamy, Soundararajan; Hao, Qin; Hogan, Kirk; Moltke, Lisa Lvon; Greenblatt, David J; Court, Michael H. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes:. Pharmacogenetics. 2004-04, 14 (4). ISSN 0960-314X. doi:10.1097/00008571-200404000-00002 （英语）.
Alberti, Siegfried; Chiesa, Alberto; Andrisano, Costanza; Serretti, Alessandro. Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression: A Meta-Analysis. Journal of Clinical Psychopharmacology. 2015-06, 35 (3). ISSN 0271-0749. doi:10.1097/JCP.0000000000000329 （英语）.
Etminan, Mahyar; Sodhi, Mohit; Procyshyn, Ric M.; Guo, Michael; Carleton, Bruce C. Risk of hair loss with different antidepressants: a comparative retrospective cohort study. International Clinical Psychopharmacology. 2018-01, 33 (1). ISSN 0268-1315. doi:10.1097/YIC.0000000000000191 （英语）.
Ketter, Terence A.; Jenkins, Janice B.; Schroeder, David H.; Pazzaglia, Peggy J.; Marangell, Lauren B.; George, Mark S.; Callahan, Ann M.; Hinton, Melvin L.; Chao, John; Post, Robert M. Carbamazepine but not Valproate Induces Bupropion Metabolism:. Journal of Clinical Psychopharmacology. 1995-10, 15 (5). ISSN 0271-0749. doi:10.1097/00004714-199510000-00004 （英语）.

medicines.org.uk

Zyban 150 mg prolonged release film-coated tablets – Summary of Product Characteristics (SPC). electronic Medicines Compendium. GlaxoSmithKline UK. 1 August 2013 [22 October 2013]. （原始内容存档于2015-09-20）.

medicinescomplete.com

Brayfield, A (编). Bupropion. Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. 22 October 2013 [18 July 2014].

medscape.com

Waknine Y. FDA Approvals: Advair, Relistor, Aplenzin [FDA批准：Advair、Relistor、Aplenzin]. 美迪网（英语：Medscape）. 8 May 2008 [9 May 2008]. （原始内容存档于6 July 2022）（英语）.

nbcnews.com

Stenson J. Report questions generic antidepressant [报告质疑仿制抗抑郁药]. NBC新聞. 12 October 2007 [13 October 2007]. （原始内容存档于11 October 2013）（英语）.

nih.gov

ncbi.nlm.nih.gov

Zhu, A. Z. X.; Zhou, Q.; Cox, L. S.; Ahluwalia, J. S.; Benowitz, N. L.; Tyndale, R. F. Gene Variants in CYP2C19 Are Associated with Altered In Vivo Bupropion Pharmacokinetics but Not Bupropion-Assisted Smoking Cessation Outcomes. Drug Metabolism and Disposition. 3 September 2014, 42 (11): 1971–1977. PMID 25187485. doi:10.1124/dmd.114.060285.
Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs. 2009,. 23 Suppl 1: 21–31. PMID 19621975. doi:10.2165/00023210-200923000-00004.
Childress, A. C.; Sallee, F. R. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder. Drugs of Today (Barcelona, Spain: 1998). 2012, 48 (3): 207–217. ISSN 1699-3993. PMID 22462040. doi:10.1358/dot.2012.48.3.1750904.
Bupropion (By mouth). PubMed Health. Bethesda, USA: National Institute of Health. 1 June 2014 [18 July 2014]. （原始内容存档于2013-11-09）.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018-04, 391 (10128) [2024-09-28]. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7. （原始内容存档于2025-02-17）（英语）.
Hengartner, Michael P.; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PLoS ONE. 2020-02-26, 15 (2). ISSN 1932-6203. PMC 7043778 . PMID 32101579. doi:10.1371/journal.pone.0229381.
Stone, Marc B; Yaseen, Zimri S; Miller, Brian J; Richardville, Kyle; Kalaria, Shamir N; Kirsch, Irving. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. The BMJ. 2022-08-02, 378 [2024-09-28]. ISSN 0959-8138. PMC 9344377 . PMID 35918097. doi:10.1136/bmj-2021-067606. （原始内容存档于2024-06-11）.
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology. 2016-04, 6 (2). ISSN 2045-1253. PMC 4837968 . PMID 27141292. doi:10.1177/2045125316629071.
Gartlehner, Gerald; Nussbaumer‐Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G; Winkler, Dietmar. Second‐generation antidepressants for preventing seasonal affective disorder in adults. The Cochrane Database of Systematic Reviews. 2019-03-18, 2019 (3) [2024-09-28]. ISSN 1469-493X. PMC 6422318 . PMID 30883669. doi:10.1002/14651858.CD011268.pub3. （原始内容存档于2024-10-06）.
Li, Dian-Jeng; Tseng, Ping-Tao; Chen, Yen-Wen; Wu, Ching-Kuan; Lin, Pao-Yen. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines. Medicine. 2016-03, 95 (13). ISSN 0025-7974. PMC 4998539 . PMID 27043678. doi:10.1097/MD.0000000000003165 （英语）.
Baldwin, David S.; Papakostas, George I. Symptoms of fatigue and sleepiness in major depressive disorder. The Journal of Clinical Psychiatry. 2006,. 67 Suppl 6 [2024-09-28]. ISSN 0160-6689. PMID 16848671. （原始内容存档于2025-02-04）.
Naguy, Ahmed; Badr, Bassem H. M. Bupropion-myth-busting!. CNS spectrums. 2022-10, 27 (5). ISSN 1092-8529. PMID 33843549. doi:10.1017/S1092852921000365.
Wilkes, Scott. The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease. 2008-03, 3 (1) [2024-09-30]. ISSN 1176-9106. PMC 2528204 . PMID 18488428. （原始内容存档于2022-10-15）.
Hajizadeh, Anisa; Howes, Seth; Theodoulou, Annika; Klemperer, Elias; Hartmann-Boyce, Jamie; Livingstone-Banks, Jonathan; Lindson, Nicola. Cochrane Tobacco Addiction Group , 编. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews. 2023-05-24, 2023 (5). PMC 10207863 . PMID 37230961. doi:10.1002/14651858.CD000031.pub6 （英语）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12-11, 6 [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2023-10-11）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12, 6 (1) [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2025-03-02）（英语）.
Wolraich, Mark L.; Hagan, Joseph F.; Allan, Carla; Chan, Eugenia; Davison, Dale; Earls, Marian; Evans, Steven W.; Flinn, Susan K.; Froehlich, Tanya; Frost, Jennifer; Holbrook, Joseph R. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019-10, 144 (4). ISSN 0031-4005. PMC 7067282 . PMID 31570648. doi:10.1542/peds.2019-2528.
Verbeeck, Wim; Bekkering, Geertruida E; Van den Noortgate, Wim; Kramers, Cornelis. Cochrane Developmental, Psychosocial and Learning Problems Group , 编. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews. 2017-10-02, 2017 (10). PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2 （英语）.
Elliott, Jesse; Johnston, Amy; Husereau, Don; Kelly, Shannon E.; Eagles, Caroline; Charach, Alice; Hsieh, Shu-Ching; Bai, Zemin; Hossain, Alomgir; Skidmore, Becky; Tsakonas, Eva. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS ONE. 2020-10-21, 15 (10). ISSN 1932-6203. PMC 7577505 . PMID 33085721. doi:10.1371/journal.pone.0240584.
Cortese, Samuele; Adamo, Nicoletta; Del Giovane, Cinzia; Mohr-Jensen, Christina; Hayes, Adrian J; Carucci, Sara; Atkinson, Lauren Z; Tessari, Luca; Banaschewski, Tobias; Coghill, David; Hollis, Chris. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-09, 5 (9). ISSN 2215-0366. PMC 6109107 . PMID 30097390. doi:10.1016/S2215-0366(18)30269-4.
Wilens, Timothy E; Morrison, Nicholas R; Prince, Jefferson. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert review of neurotherapeutics. 2011-10, 11 (10) [2024-09-29]. ISSN 1473-7175. PMC 3229037 . PMID 21955201. doi:10.1586/ern.11.137. （原始内容存档于2023-09-25）.
Shalabi, Abdelrahman R.; Walther, Donna; Baumann, Michael H.; Glennon, Richard A. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. ACS Chemical Neuroscience. 2017-06-21, 8 (6). ISSN 1948-7193. PMC 7261150 . PMID 28220701. doi:10.1021/acschemneuro.7b00055 （英语）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10). ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10) [2025-03-22]. ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2. （原始内容存档于2025-02-03）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R.A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1) [2025-03-22]. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077. （原始内容存档于2025-02-06）（英语）.
Preskorn, S. H. Should bupropion dosage be adjusted based upon therapeutic drug monitoring?. Psychopharmacology Bulletin. 1991, 27 (4). ISSN 0048-5764. PMID 1813908.
Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. Antidepressant Withdrawal and Rebound Phenomena. Deutsches Ärzteblatt international. 2019-05-17. ISSN 1866-0452. PMC 6637660 . PMID 31288917. doi:10.3238/arztebl.2019.0355.
White, Nicole C.; Litovitz, Toby; Clancy, Cathleen. Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology. 2008-12, 4 (4). ISSN 1556-9039. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207 （英语）.
Fava M, Rush AJ, Thase ME, Clayton A, Stahl SM, Pradko JF, Johnston JA. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL [15年盐酸安非他酮临床经验：从安非他酮到安非他酮SR再到安非他酮XL]. Primary Care Companion to the Journal of Clinical Psychiatry. 2005, 7 (3): 106–113. PMC 1163271 . PMID 16027765. doi:10.4088/pcc.v07n0305 （英语）.

pubmed.ncbi.nlm.nih.gov

Baldwin, David S.; Papakostas, George I. Symptoms of fatigue and sleepiness in major depressive disorder. The Journal of Clinical Psychiatry. 2006,. 67 Suppl 6 [2024-09-28]. ISSN 0160-6689. PMID 16848671. （原始内容存档于2025-02-04）.
Naguy, Ahmed; Badr, Bassem H. M. Bupropion-myth-busting!. CNS spectrums. 2022-10, 27 (5). ISSN 1092-8529. PMID 33843549. doi:10.1017/S1092852921000365.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10). ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10) [2025-03-22]. ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2. （原始内容存档于2025-02-03）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Preskorn, S. H. Should bupropion dosage be adjusted based upon therapeutic drug monitoring?. Psychopharmacology Bulletin. 1991, 27 (4). ISSN 0048-5764. PMID 1813908.

dailymed.nlm.nih.gov

BUPROPION HYDROCHLORIDE tablet, film coated [Sandoz Inc]. DailyMed. Sandoz, Inc. April 2013 [22 October 2013]. （原始内容存档于2013-07-04）.
WELLBUTRIN (bupropion hydrochloride) tablet, film coated [GlaxoSmithKline LLC]. DailyMed. GlaxoSmithKline LLC. March 2013 [22 October 2013]. （原始内容存档于2013-10-23）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-09-30]. （原始内容存档于2020-06-04）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-10-02]. （原始内容存档于2020-06-04）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-09-27]. （原始内容存档于2020-06-04）.
Aplenzin – bupropion hydrobromide tablet, extended-release [Aplenzin - 氢溴酸安非他酮缓释片]. DailyMed. 2 June 2020 [21 October 2020]. （原始内容存档于26 October 2020）（英语）.

nytimes.com

Thomas K, Schmidt MS. Glaxo agrees to pay $3 billion in fraud settlement [葛兰素同意支付30亿美元解决欺诈案]. The New York Times. 2 July 2012 [26 February 2017]. （原始内容存档于2 March 2017）（英语）.

peoplespharmacy.com

Generic drug equality questioned [仿制药等同性受质疑]. 12 October 2007 [13 October 2007]. （原始内容存档于20 October 2012）（英语）.

pharmaceutical-journal.com

Lipanovic D. Bupropion to be made available in the UK again from December 2023, says manufacturer [制造商称安非他酮将于2023年12月再次在英国上市]. The Pharmaceutical Journal. 6 September 2023 [24 October 2023]. （原始内容存档于11 October 2023）（美国英语）.

psychiatrist.com

Papakostas, George I.; Stahl, Stephen M.; Krishen, Alok; Seifert, Cheryl A.; Tucker, Vivian L.; Goodale, Elizabeth P.; Fava, Maurizio. Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression): A Pooled Analysis of 10 Studies. The Journal of Clinical Psychiatry. 2008-08-15, 69 (8). ISSN 0160-6689. doi:10.4088/JCP.v69n0812.
Feinberg, S. Shalom. Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication. The Journal of Clinical Psychiatry. 2004-11-15, 65 (11) [2024-10-02]. ISSN 0160-6689. doi:10.4088/JCP.v65n1113. （原始内容存档于2025-01-12）.

psychiatryonline.org

Nelson, J. Craig; Spyker, Daniel A. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. American Journal of Psychiatry. 2017-05-01, 174 (5). ISSN 0002-953X. doi:10.1176/appi.ajp.2016.16050523 （英语）.

springer.com

link.springer.com

Dhillon, Sohita; Yang, Lily P H; Curran, Monique P. Bupropion: A Review of its Use in the Management of Major Depressive Disorder. Drugs. 2008, 68 (5). ISSN 0012-6667. doi:10.2165/00003495-200868050-00011 （英语）.
Pisani, Francesco; Oteri, Giancarla; Costa, Cinzia; Di Raimondo, Giorgio; Di Perri, Raoul. Effects of Psychotropic Drugs on Seizure Threshold:. Drug Safety. 2002, 25 (2). ISSN 0114-5916. doi:10.2165/00002018-200225020-00004 （英语）.
White, Nicole C.; Litovitz, Toby; Clancy, Cathleen. Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology. 2008-12, 4 (4). ISSN 1556-9039. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207 （英语）.

tandfonline.com

Costa, Rafaela; Oliveira, Nuno G.; Dinis-Oliveira, Ricardo Jorge. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metabolism Reviews. 2019-07-03, 51 (3). ISSN 0360-2532. doi:10.1080/03602532.2019.1620763 （英语）.

tga.gov.au

ebs.tga.gov.au

PRODUCT INFORMATION ZYBAN® SUSTAINED RELEASE TABLETS. TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 19 April 2013 [22 October 2013]. （原始内容存档于2016-12-07）.
Prexaton Bupropion hydrochloride PRODUCT INFORMATION. TGA eBusiness Services. Ascent Pharma Pty Ltd. 2 October 2012 [22 October 2013]. （原始内容存档于2016-12-07）.

ualberta.ca

journals.library.ualberta.ca

Todor, Ioana; Popa, Adina; Neag, Maria; Muntean, Dana; Bocsan, Corina; Buzoianu, Anca; Vlase, Laurian; Gheldiu, Ana-Maria; Briciu, Corina. Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. Journal of Pharmacy & Pharmaceutical Sciences. 2016-06-15, 19 (2). ISSN 1482-1826. doi:10.18433/J3H03R.

web.archive.org

Zyban 150 mg prolonged release film-coated tablets – Summary of Product Characteristics (SPC). electronic Medicines Compendium. GlaxoSmithKline UK. 1 August 2013 [22 October 2013]. （原始内容存档于2015-09-20）.
BUPROPION HYDROCHLORIDE tablet, film coated [Sandoz Inc]. DailyMed. Sandoz, Inc. April 2013 [22 October 2013]. （原始内容存档于2013-07-04）.
PRODUCT INFORMATION ZYBAN® SUSTAINED RELEASE TABLETS. TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 19 April 2013 [22 October 2013]. （原始内容存档于2016-12-07）.
WELLBUTRIN (bupropion hydrochloride) tablet, film coated [GlaxoSmithKline LLC]. DailyMed. GlaxoSmithKline LLC. March 2013 [22 October 2013]. （原始内容存档于2013-10-23）.
Prexaton Bupropion hydrochloride PRODUCT INFORMATION. TGA eBusiness Services. Ascent Pharma Pty Ltd. 2 October 2012 [22 October 2013]. （原始内容存档于2016-12-07）.
Dr. Ian Morton, I.K. Morton, Judith M. Hall. Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. 31 October 1999: 57– [2015-09-02]. ISBN 978-0-7514-0499-9. （原始内容存档于2016-04-27）.
Dictionary of Organic Compounds. CRC Press. : 104– [2015-09-02]. ISBN 978-0-412-54090-5. （原始内容存档于2016-04-30）.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000: 38– [2015-09-02]. ISBN 978-3-88763-075-1. （原始内容存档于2016-04-30）.
Bupropion (By mouth). PubMed Health. Bethesda, USA: National Institute of Health. 1 June 2014 [18 July 2014]. （原始内容存档于2013-11-09）.
衛署藥製字第054977號. info.fda.gov.tw. [2022-02-20]. （原始内容存档于2022-02-20）.
Cipriani, Andrea; Furukawa, Toshiaki A; Salanti, Georgia; Geddes, John R; Higgins, Julian PT; Churchill, Rachel; Watanabe, Norio; Nakagawa, Atsuo; Omori, Ichiro M; McGuire, Hugh; Tansella, Michele. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. The Lancet. 2009-02, 373 (9665) [2024-09-28]. doi:10.1016/S0140-6736(09)60046-5. （原始内容存档于2025-03-31）（英语）.
Monden, Rei; Roest, Annelieke M.; van Ravenzwaaij, Don; Wagenmakers, Eric-Jan; Morey, Richard; Wardenaar, Klaas J.; de Jonge, Peter. The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews. Journal of Affective Disorders. 2018-08, 235 [2024-09-28]. doi:10.1016/j.jad.2018.04.040. （原始内容存档于2024-09-19）（英语）.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018-04, 391 (10128) [2024-09-28]. PMC 5889788 . PMID 29477251. doi:10.1016/S0140-6736(17)32802-7. （原始内容存档于2025-02-17）（英语）.
Stone, Marc B; Yaseen, Zimri S; Miller, Brian J; Richardville, Kyle; Kalaria, Shamir N; Kirsch, Irving. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. The BMJ. 2022-08-02, 378 [2024-09-28]. ISSN 0959-8138. PMC 9344377 . PMID 35918097. doi:10.1136/bmj-2021-067606. （原始内容存档于2024-06-11）.
Gartlehner, Gerald; Nussbaumer‐Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G; Winkler, Dietmar. Second‐generation antidepressants for preventing seasonal affective disorder in adults. The Cochrane Database of Systematic Reviews. 2019-03-18, 2019 (3) [2024-09-28]. ISSN 1469-493X. PMC 6422318 . PMID 30883669. doi:10.1002/14651858.CD011268.pub3. （原始内容存档于2024-10-06）.
Antidepressant-Associated Sexual Dysfunction: A Potentially Avoidable Therapeutic Challenge « Hacked by 4Ri3 60ndr0n9. web.archive.org. 2020-06-04 [2024-09-28]. 原始内容存档于2020-06-04.
Baldwin, David S.; Papakostas, George I. Symptoms of fatigue and sleepiness in major depressive disorder. The Journal of Clinical Psychiatry. 2006,. 67 Suppl 6 [2024-09-28]. ISSN 0160-6689. PMID 16848671. （原始内容存档于2025-02-04）.
Wilkes, Scott. The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease. 2008-03, 3 (1) [2024-09-30]. ISSN 1176-9106. PMC 2528204 . PMID 18488428. （原始内容存档于2022-10-15）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12-11, 6 [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2023-10-11）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12, 6 (1) [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2025-03-02）（英语）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-09-30]. （原始内容存档于2020-06-04）.
Rosen, Laura J.; Galili, Tal; Kott, Jeffrey; Goodman, Mark; Freedman, Laurence S. Diminishing benefit of smoking cessation medications during the first year: a meta‐analysis of randomized controlled trials. Addiction. 2018-05, 113 (5) [2024-09-30]. ISSN 0965-2140. doi:10.1111/add.14134. （原始内容存档于2025-04-09）（英语）.
Selph, Shelley; Patnode, Carrie; Bailey, Steffani R.; Pappas, Miranda; Stoner, Ryan; Chou, Roger. Primary Care–Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020-04-28, 323 (16) [2024-09-30]. ISSN 0098-7484. doi:10.1001/jama.2020.3332. （原始内容存档于2025-03-17）（英语）.
Wilens, Timothy E; Morrison, Nicholas R; Prince, Jefferson. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert review of neurotherapeutics. 2011-10, 11 (10) [2024-09-29]. ISSN 1473-7175. PMC 3229037 . PMID 21955201. doi:10.1586/ern.11.137. （原始内容存档于2023-09-25）.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10) [2025-03-22]. ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2. （原始内容存档于2025-02-03）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R.A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1) [2025-03-22]. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077. （原始内容存档于2025-02-06）（英语）.
"Antidepressants and suicidality in adults: statistical evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)". （原始内容存档于2007-07-27）（英语）.
Highlight os Prescribing Information: CONTRAVE (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use (PDF). [2024-10-02]. （原始内容存档 (PDF)于2020-10-19）（英语）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-10-02]. （原始内容存档于2020-06-04）.
Feinberg, S. Shalom. Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication. The Journal of Clinical Psychiatry. 2004-11-15, 65 (11) [2024-10-02]. ISSN 0160-6689. doi:10.4088/JCP.v65n1113. （原始内容存档于2025-01-12）.
DailyMed - WELLBUTRIN SR- bupropion hydrochloride tablet, film coated. dailymed.nlm.nih.gov. [2024-09-27]. （原始内容存档于2020-06-04）.
Wellbutrin approval package [Wellbutrin批准文件] (PDF). U.S. 美国食品药品监督管理局 (FDA). 30 December 1985 [5 May 2020]. （原始内容存档 (PDF)于27 November 2020）（英语）.
Wellbutrin entry in the Orange Book [Wellbutrin在橙皮书中的条目]. U.S. Food and Drug Administration Center for Drug Evaluation and Research. [18 August 2007]. （原始内容存档于25 February 2011）（英语）.
Bupropion (Wellbutrin) [安非他酮（Wellbutrin）]. eMedExpert.com. 31 March 2008 [20 August 2013]. （原始内容存档于6 August 2013）（英语）.
Whitten L. Bupropion helps people with schizophrenia quit smoking [安非他酮帮助精神分裂症患者戒烟]. National Institute on Drug Abuse Research Findings. April 2006, 20 (5) [27 May 2013]. （原始内容存档于5 August 2007）（英语）.
Drug Approval Package: Wellbutrin XL (Bupropion HCI) NDA #021515 [药物批准包：Wellbutrin XL（盐酸安非他酮）NDA #021515]. U.S. 美国食品药品监督管理局 (FDA). 22 April 2005 [4 December 2019]. （原始内容存档于5 December 2019）（英语）.
Drug Approval Package: Zyban NDA# 020711 [药物批准包：Zyban NDA# 020711]. U.S. 美国食品药品监督管理局 (FDA). 8 August 2003 [4 December 2019]. （原始内容存档于5 December 2019）（英语）.
FDA approval letter [FDA批准信] (PDF). U.S. 美国食品药品监督管理局 (FDA). 6 December 2006 [21 October 2020]. （原始内容存档 (PDF)于1 November 2020）（英语）.
Seasonal affective disorder drug Wellbutrin XL wins approval [季节性情感障碍药物Wellbutrin XL获批准]. CNN. 14 June 2006 [19 August 2007]. （原始内容存档于30 June 2007）（英语）.
Generic drug equality questioned [仿制药等同性受质疑]. 12 October 2007 [13 October 2007]. （原始内容存档于20 October 2012）（英语）.
Stenson J. Report questions generic antidepressant [报告质疑仿制抗抑郁药]. NBC新聞. 12 October 2007 [13 October 2007]. （原始内容存档于11 October 2013）（英语）.
Review of therapeutic equivalence: generic bupropion XL 300 mg and Wellbutrin XL 300 mg [治疗等效性评审：仿制安非他酮XL 300毫克和Wellbutrin XL 300毫克]. 美国食品药品监督管理局. [19 April 2008]. （原始内容存档于6 June 2011）（英语）.
Budeprion XL 300 mg not therapeutically equivalent to Wellbutrin XL 300 mg [Budeprion XL 300毫克与Wellbutrin XL 300毫克不具有治疗等效性]. U.S. 美国食品药品监督管理局 (FDA). 3 October 2012 [23 March 2013]. （原始内容存档于13 December 2019）（英语）. 本文含有此來源中屬於公有领域的内容。
Aplenzin – bupropion hydrobromide tablet, extended-release [Aplenzin - 氢溴酸安非他酮缓释片]. DailyMed. 2 June 2020 [21 October 2020]. （原始内容存档于26 October 2020）（英语）.
Waknine Y. FDA Approvals: Advair, Relistor, Aplenzin [FDA批准：Advair、Relistor、Aplenzin]. 美迪网（英语：Medscape）. 8 May 2008 [9 May 2008]. （原始内容存档于6 July 2022）（英语）.
Drug Approval Package: Aplenzin (Bupropion Hydrobromide) NDA 22108 [药物批准包：Aplenzin（氢溴酸安非他酮）NDA 22108]. U.S. 美国食品药品监督管理局 (FDA). 24 December 1999 [5 May 2020]. （原始内容存档于15 August 2020）（英语）.
CENTER FOR DRUG EVALUATION AND RESEARCH. Application number 22-108 Cross Dicipline Team Leader Review (PDF). accessdata.fda.gov. [2025-03-09]. （原始内容存档 (PDF)于2025-02-08）.
Public Health Advisory: FDA requires new boxed warnings for the smoking cessation drugs Chantix and Zyban [公共卫生警告：FDA要求戒烟药物Chantix和Zyban加注新的黑框警告]. U.S. 美国食品药品监督管理局 (FDA). 1 July 2009 [3 July 2009]. （原始内容存档于19 October 2010）（英语）.
The smoking cessation aids varenicline (marketed as Chantix) and bupropion (marketed as Zyban and generics) suicidal ideation and behavior [戒烟辅助药物伐尼克兰（商品名Chantix）和安非他酮（商品名Zyban及仿制药）的自杀意念和行为] (PDF). Drug Safety Newsletter. 2009, 2 (1): 1–4 [16 December 2019]. （原始内容 (PDF)存档于11 February 2017）（英语）.
Safety Alerts for Human Medical Products – Chantix (varenicline) and Zyban (bupropion) [人用医疗产品安全警报 - Chantix (伐尼克兰) 和 Zyban (安非他酮) - 药物安全通讯 - 精神健康副作用修订]. Drug Safety Communication – Mental Health Side Effects Revised. U.S. 美国食品药品监督管理局 (FDA). 16 December 2016 [20 December 2016]. （原始内容存档于20 December 2016）（英语）.
Thomas K, Schmidt MS. Glaxo agrees to pay $3 billion in fraud settlement [葛兰素同意支付30亿美元解决欺诈案]. The New York Times. 2 July 2012 [26 February 2017]. （原始内容存档于2 March 2017）（英语）.
Committee for Medicinal Products for Human Use (CHMP). EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs [EMA建议由于Micro Therapeutic Research Labs的不可靠研究而暂停药品]. European Medicines Agency. 24 March 2017 [26 November 2020]. （原始内容存档于26 October 2020）（英语）.
Committee for Medicinal Products for Human Use (CHMP). Products for which the marketing authorisations are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP [CHMP建议暂停上市许可的产品和不符合授权标准的上市许可申请] (PDF). European Medicines Agency. 23 March 2017 [26 November 2020]. （原始内容存档 (PDF)于19 January 2021）（英语）.
EMA advises companies on steps to take avoid nitrosamines in human medicines [EMA建议公司采取措施避免人用药品中的亚硝胺]. European Medicines Agency (EMA). 26 September 2019 [24 October 2023]. （原始内容存档于11 November 2023）（英语）.
Lipanovic D. Bupropion to be made available in the UK again from December 2023, says manufacturer [制造商称安非他酮将于2023年12月再次在英国上市]. The Pharmaceutical Journal. 6 September 2023 [24 October 2023]. （原始内容存档于11 October 2023）（美国英语）.

wikipedia.org

en.wikipedia.org

Waknine Y. FDA Approvals: Advair, Relistor, Aplenzin [FDA批准：Advair、Relistor、Aplenzin]. 美迪网（英语：Medscape）. 8 May 2008 [9 May 2008]. （原始内容存档于6 July 2022）（英语）.

wiley.com

doi.wiley.com

Hajizadeh, Anisa; Howes, Seth; Theodoulou, Annika; Klemperer, Elias; Hartmann-Boyce, Jamie; Livingstone-Banks, Jonathan; Lindson, Nicola. Cochrane Tobacco Addiction Group , 编. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews. 2023-05-24, 2023 (5). PMC 10207863 . PMID 37230961. doi:10.1002/14651858.CD000031.pub6 （英语）.
Livingstone-Banks, Jonathan; Norris, Emma; Hartmann-Boyce, Jamie; West, Robert; Jarvis, Martin; Chubb, Emma; Hajek, Peter. Cochrane Tobacco Addiction Group , 编. Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2019-10-28. doi:10.1002/14651858.CD003999.pub6 （英语）.
Claire, Ravinder; Chamberlain, Catherine; Davey, Mary-Ann; Cooper, Sue E; Berlin, Ivan; Leonardi-Bee, Jo; Coleman, Tim. Cochrane Tobacco Addiction Group , 编. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2020-03-04, 2020 (3). doi:10.1002/14651858.CD010078.pub3 （英语）.
Verbeeck, Wim; Bekkering, Geertruida E; Van den Noortgate, Wim; Kramers, Cornelis. Cochrane Developmental, Psychosocial and Learning Problems Group , 编. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews. 2017-10-02, 2017 (10). PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2 （英语）.

onlinelibrary.wiley.com

Rosen, Laura J.; Galili, Tal; Kott, Jeffrey; Goodman, Mark; Freedman, Laurence S. Diminishing benefit of smoking cessation medications during the first year: a meta‐analysis of randomized controlled trials. Addiction. 2018-05, 113 (5) [2024-09-30]. ISSN 0965-2140. doi:10.1111/add.14134. （原始内容存档于2025-04-09）（英语）.
Protti, Michele; Mandrioli, Roberto; Marasca, Camilla; Cavalli, Andrea; Serretti, Alessandro; Mercolini, Laura. New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews. 2020-09, 40 (5). ISSN 0198-6325. doi:10.1002/med.21671 （英语）.

worldcat.org

Childress, A. C.; Sallee, F. R. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder. Drugs of Today (Barcelona, Spain: 1998). 2012, 48 (3): 207–217. ISSN 1699-3993. PMID 22462040. doi:10.1358/dot.2012.48.3.1750904.
Hengartner, Michael P.; Jakobsen, Janus C.; Sørensen, Anders; Plöderl, Martin. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PLoS ONE. 2020-02-26, 15 (2). ISSN 1932-6203. PMC 7043778 . PMID 32101579. doi:10.1371/journal.pone.0229381.
Stone, Marc B; Yaseen, Zimri S; Miller, Brian J; Richardville, Kyle; Kalaria, Shamir N; Kirsch, Irving. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis. The BMJ. 2022-08-02, 378 [2024-09-28]. ISSN 0959-8138. PMC 9344377 . PMID 35918097. doi:10.1136/bmj-2021-067606. （原始内容存档于2024-06-11）.
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology. 2016-04, 6 (2). ISSN 2045-1253. PMC 4837968 . PMID 27141292. doi:10.1177/2045125316629071.
Gartlehner, Gerald; Nussbaumer‐Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G; Winkler, Dietmar. Second‐generation antidepressants for preventing seasonal affective disorder in adults. The Cochrane Database of Systematic Reviews. 2019-03-18, 2019 (3) [2024-09-28]. ISSN 1469-493X. PMC 6422318 . PMID 30883669. doi:10.1002/14651858.CD011268.pub3. （原始内容存档于2024-10-06）.
Li, Dian-Jeng; Tseng, Ping-Tao; Chen, Yen-Wen; Wu, Ching-Kuan; Lin, Pao-Yen. Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines. Medicine. 2016-03, 95 (13). ISSN 0025-7974. PMC 4998539 . PMID 27043678. doi:10.1097/MD.0000000000003165 （英语）.
Dhillon, Sohita; Yang, Lily P H; Curran, Monique P. Bupropion: A Review of its Use in the Management of Major Depressive Disorder. Drugs. 2008, 68 (5). ISSN 0012-6667. doi:10.2165/00003495-200868050-00011 （英语）.
Baldwin, David S.; Papakostas, George I. Symptoms of fatigue and sleepiness in major depressive disorder. The Journal of Clinical Psychiatry. 2006,. 67 Suppl 6 [2024-09-28]. ISSN 0160-6689. PMID 16848671. （原始内容存档于2025-02-04）.
Papakostas, George I.; Stahl, Stephen M.; Krishen, Alok; Seifert, Cheryl A.; Tucker, Vivian L.; Goodale, Elizabeth P.; Fava, Maurizio. Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression): A Pooled Analysis of 10 Studies. The Journal of Clinical Psychiatry. 2008-08-15, 69 (8). ISSN 0160-6689. doi:10.4088/JCP.v69n0812.
Naguy, Ahmed; Badr, Bassem H. M. Bupropion-myth-busting!. CNS spectrums. 2022-10, 27 (5). ISSN 1092-8529. PMID 33843549. doi:10.1017/S1092852921000365.
Wilkes, Scott. The use of bupropion SR in cigarette smoking cessation. International Journal of Chronic Obstructive Pulmonary Disease. 2008-03, 3 (1) [2024-09-30]. ISSN 1176-9106. PMC 2528204 . PMID 18488428. （原始内容存档于2022-10-15）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12-11, 6 [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2023-10-11）.
Wu, Ping; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006-12, 6 (1) [2024-09-30]. ISSN 1471-2458. PMC 1764891 . PMID 17156479. doi:10.1186/1471-2458-6-300. （原始内容存档于2025-03-02）（英语）.
Rosen, Laura J.; Galili, Tal; Kott, Jeffrey; Goodman, Mark; Freedman, Laurence S. Diminishing benefit of smoking cessation medications during the first year: a meta‐analysis of randomized controlled trials. Addiction. 2018-05, 113 (5) [2024-09-30]. ISSN 0965-2140. doi:10.1111/add.14134. （原始内容存档于2025-04-09）（英语）.
Patnode, Carrie D.; Henderson, Jillian T.; Coppola, Erin L.; Melnikow, Joy; Durbin, Shauna; Thomas, Rachel G. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021-01-19, 325 (3). ISSN 0098-7484. doi:10.1001/jama.2020.23541 （英语）.
Selph, Shelley; Patnode, Carrie; Bailey, Steffani R.; Pappas, Miranda; Stoner, Ryan; Chou, Roger. Primary Care–Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020-04-28, 323 (16) [2024-09-30]. ISSN 0098-7484. doi:10.1001/jama.2020.3332. （原始内容存档于2025-03-17）（英语）.
Wolraich, Mark L.; Hagan, Joseph F.; Allan, Carla; Chan, Eugenia; Davison, Dale; Earls, Marian; Evans, Steven W.; Flinn, Susan K.; Froehlich, Tanya; Frost, Jennifer; Holbrook, Joseph R. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019-10, 144 (4). ISSN 0031-4005. PMC 7067282 . PMID 31570648. doi:10.1542/peds.2019-2528.
Elliott, Jesse; Johnston, Amy; Husereau, Don; Kelly, Shannon E.; Eagles, Caroline; Charach, Alice; Hsieh, Shu-Ching; Bai, Zemin; Hossain, Alomgir; Skidmore, Becky; Tsakonas, Eva. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS ONE. 2020-10-21, 15 (10). ISSN 1932-6203. PMC 7577505 . PMID 33085721. doi:10.1371/journal.pone.0240584.
Cortese, Samuele; Adamo, Nicoletta; Del Giovane, Cinzia; Mohr-Jensen, Christina; Hayes, Adrian J; Carucci, Sara; Atkinson, Lauren Z; Tessari, Luca; Banaschewski, Tobias; Coghill, David; Hollis, Chris. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-09, 5 (9). ISSN 2215-0366. PMC 6109107 . PMID 30097390. doi:10.1016/S2215-0366(18)30269-4.
Ng, Qin Xiang. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 2017-03, 27 (2). ISSN 1044-5463. doi:10.1089/cap.2016.0124 （英语）.
Wilens, Timothy E; Morrison, Nicholas R; Prince, Jefferson. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert review of neurotherapeutics. 2011-10, 11 (10) [2024-09-29]. ISSN 1473-7175. PMC 3229037 . PMID 21955201. doi:10.1586/ern.11.137. （原始内容存档于2023-09-25）.
Li, Zhaoping; Maglione, Margaret; Tu, Wenli; Mojica, Walter; Arterburn, David; Shugarman, Lisa R.; Hilton, Lara; Suttorp, Marika; Solomon, Vanessa; Shekelle, Paul G.; Morton, Sally C. Meta-Analysis: Pharmacologic Treatment of Obesity. Annals of Internal Medicine. 2005-04-05, 142 (7). ISSN 0003-4819. doi:10.7326/0003-4819-142-7-200504050-00012 （英语）.
Costa, Rafaela; Oliveira, Nuno G.; Dinis-Oliveira, Ricardo Jorge. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metabolism Reviews. 2019-07-03, 51 (3). ISSN 0360-2532. doi:10.1080/03602532.2019.1620763 （英语）.
Shalabi, Abdelrahman R.; Walther, Donna; Baumann, Michael H.; Glennon, Richard A. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. ACS Chemical Neuroscience. 2017-06-21, 8 (6). ISSN 1948-7193. PMC 7261150 . PMID 28220701. doi:10.1021/acschemneuro.7b00055 （英语）.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Hart, Xenia M.; Spangemacher, Moritz; Defert, Julie; Uchida, Hiroyuki; Gründer, Gerhard. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants. Therapeutic Drug Monitoring. 2024-04, 46 (2). ISSN 0163-4356. doi:10.1097/FTD.0000000000001142 （英语）.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10). ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2.
Verbeeck, Wim; Bekkering, Geertruida E.; Van den Noortgate, Wim; Kramers, Cornelis. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. The Cochrane Database of Systematic Reviews. 2017-10-02, 10 (10) [2025-03-22]. ISSN 1469-493X. PMC 6485546 . PMID 28965364. doi:10.1002/14651858.CD009504.pub2. （原始内容存档于2025-02-03）.
Egerton, Alice; Shotbolt, John P.; Stokes, Paul R. A.; Hirani, Ella; Ahmad, Rabia; Lappin, Julia M.; Reeves, Suzanne J.; Mehta, Mitul A.; Howes, Oliver D.; Grasby, Paul M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. NeuroImage. 2010-03, 50 (1). ISSN 1095-9572. PMC 4135078 . PMID 19969097. doi:10.1016/j.neuroimage.2009.11.077.
Hesse, Leah M; He, Ping; Krishnaswamy, Soundararajan; Hao, Qin; Hogan, Kirk; Moltke, Lisa Lvon; Greenblatt, David J; Court, Michael H. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes:. Pharmacogenetics. 2004-04, 14 (4). ISSN 0960-314X. doi:10.1097/00008571-200404000-00002 （英语）.
Preskorn, S. H. Should bupropion dosage be adjusted based upon therapeutic drug monitoring?. Psychopharmacology Bulletin. 1991, 27 (4). ISSN 0048-5764. PMID 1813908.
Alberti, Siegfried; Chiesa, Alberto; Andrisano, Costanza; Serretti, Alessandro. Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression: A Meta-Analysis. Journal of Clinical Psychopharmacology. 2015-06, 35 (3). ISSN 0271-0749. doi:10.1097/JCP.0000000000000329 （英语）.
Pisani, Francesco; Oteri, Giancarla; Costa, Cinzia; Di Raimondo, Giorgio; Di Perri, Raoul. Effects of Psychotropic Drugs on Seizure Threshold:. Drug Safety. 2002, 25 (2). ISSN 0114-5916. doi:10.2165/00002018-200225020-00004 （英语）.
Etminan, Mahyar; Sodhi, Mohit; Procyshyn, Ric M.; Guo, Michael; Carleton, Bruce C. Risk of hair loss with different antidepressants: a comparative retrospective cohort study. International Clinical Psychopharmacology. 2018-01, 33 (1). ISSN 0268-1315. doi:10.1097/YIC.0000000000000191 （英语）.
Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. Antidepressant Withdrawal and Rebound Phenomena. Deutsches Ärzteblatt international. 2019-05-17. ISSN 1866-0452. PMC 6637660 . PMID 31288917. doi:10.3238/arztebl.2019.0355.
Ketter, Terence A.; Jenkins, Janice B.; Schroeder, David H.; Pazzaglia, Peggy J.; Marangell, Lauren B.; George, Mark S.; Callahan, Ann M.; Hinton, Melvin L.; Chao, John; Post, Robert M. Carbamazepine but not Valproate Induces Bupropion Metabolism:. Journal of Clinical Psychopharmacology. 1995-10, 15 (5). ISSN 0271-0749. doi:10.1097/00004714-199510000-00004 （英语）.
Todor, Ioana; Popa, Adina; Neag, Maria; Muntean, Dana; Bocsan, Corina; Buzoianu, Anca; Vlase, Laurian; Gheldiu, Ana-Maria; Briciu, Corina. Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. Journal of Pharmacy & Pharmaceutical Sciences. 2016-06-15, 19 (2). ISSN 1482-1826. doi:10.18433/J3H03R.
Schmid, Yasmin; Rickli, Anna; Schaffner, Antonia; Duthaler, Urs; Grouzmann, Eric; Hysek, Cédric M.; Liechti, Matthias E. Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects. Journal of Pharmacology and Experimental Therapeutics. 2015-04, 353 (1). ISSN 0022-3565. doi:10.1124/jpet.114.222356 （英语）.
Protti, Michele; Mandrioli, Roberto; Marasca, Camilla; Cavalli, Andrea; Serretti, Alessandro; Mercolini, Laura. New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews. 2020-09, 40 (5). ISSN 0198-6325. doi:10.1002/med.21671 （英语）.
Feinberg, S. Shalom. Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication. The Journal of Clinical Psychiatry. 2004-11-15, 65 (11) [2024-10-02]. ISSN 0160-6689. doi:10.4088/JCP.v65n1113. （原始内容存档于2025-01-12）.
White, Nicole C.; Litovitz, Toby; Clancy, Cathleen. Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology. 2008-12, 4 (4). ISSN 1556-9039. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207 （英语）.
Nelson, J. Craig; Spyker, Daniel A. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. American Journal of Psychiatry. 2017-05-01, 174 (5). ISSN 0002-953X. doi:10.1176/appi.ajp.2016.16050523 （英语）.